Loading...
Derniers manuscrits de l'équipe
-
É. Mathian, Y. Drouet, A. Sexton-Oates, M.G. Papotti, G. Pelosi, et al.. Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project. ESMO Open, 2024, 9 (6), pp.103591. ⟨10.1016/j.esmoop.2024.103591⟩. ⟨hal-04655442⟩
-
-
-
Maroin Kalifi, Sophie Deguelte, Matthieu Faron, Pauline Afchain, Louis de Mestier, et al.. The Need for Centralization for Small Intestinal Neuroendocrine Tumor Surgery: A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study. Annals of Surgical Oncology, 2023, 30 (13), pp.8528-8541. ⟨10.1245/s10434-023-14276-8⟩. ⟨hal-04490380⟩
-
Benjamin Ducarouge, Anna-Rita Redavid, Camille Victoor, Ruxanda Chira, Aurélien Fonseca, et al.. Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor. Cell Death and Differentiation, 2023, 30 (10), pp.2201-2212. ⟨10.1038/s41418-023-01209-x⟩. ⟨hal-04253805⟩
-
Aziz Zaanan, Julie Henriques, Anthony Turpin, Sylvain Manfredi, Romain Coriat, et al.. Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study. JNCI Cancer Spectrum, 2023, 7 (5), pkad064. ⟨10.1093/jncics/pkad064⟩. ⟨hal-04282951⟩
Chiffres clés
40
Publications avec texte intégral